TB DRUG MONOGRAPHS
  • Home
  • Baseline & Ongoing Monitoring Tests
  • Drug Monographs
    • Amikacin
    • Bedaquiline
    • Capreomycin
    • Clarithromycin
    • Clofazimine
    • Co-Amoxiclav
    • Cycloserine
    • Delamanid
    • Ethambutol
    • Imipenem/Cilastatin
    • Isoniazid
    • Levofloxacin
    • Linezolid
    • Meropenem
    • Moxifloxacin
    • Ofloxacin
    • P-aminosalicylic acid
    • Prothionamide
    • Pyrazinamide
    • Rifabutin
    • Rifampicin
    • Rifapentine
    • Streptomycin
    • Terizidone
    • Thioacetazone
  • For patients
  • Updates
  • Publications
  • References
  • About Us
  • Contact
  • New Page
Please select the drug which you would like further information on from the drop down menu under 'Drug Monographs'.

Each monograph includes information on:

  • Dosage
  • Preparations
  • Drug level monitoring
  • Adverse effects
  • Adverse effect monitoring recommendations
  • Interactions
  • Contra-indications and cautions
  • Laboratory information

The information we have provided here is not exhaustive and is aimed as a practical tool for aid in the management of patients with MDR-TB.  A list of references is included in a separate document however the majority of these recommendations are based on expert consensus.   Feedback is welcomed.  This is a drug monitoring guideline, for treatment guidance please refer to the WHO treatment guideline http://whqlibdoc.who.int/publications/2011/9789241501583_eng.pdf and the BTS MDR-TB Clinical Advisory Service http://www.brit-thoracic.org.uk/delivery-of-respiratory-care/tuberculosis/mdrtb-clinical-advice-service.aspx.